Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal

Featuring an interview with Prof Ticiana Leal, including the following topics:

Pathophysiology and clinical signs and symptoms (0:00)
Screening and/or diagnostic approaches (5:45)
Potential impact of available therapies for small cell lung cancer (SCLC) on paraneoplastic syndromes (7:36)
Key clinical trial data for amifampridine and practicalities of its administration (14:05)
Building awareness among patients, caregivers and the oncology community (22:37)
Role of pyridostigmine in managing Lambert-Eaton myasthenic syndrome (LEMS); potential integration of EMG (electromyography) into monitoring (25:35)
Case: A man in his early 70s who receives a diagnosis of limited-stage SCLC (LS-SCLC) with LEMS and undergoes treatment (27:41)
Case: A woman in her late 70s already diagnosed with LS-SCLC who is subsequently evaluated and treated for LEMS (37:55)
Current research and potential developments in the treatment of SCLC (48:32)